Crown Place VCT PLC Crown Place Vct Plc : Annual -2-
02 Oktober 2014 - 6:08PM
UK Regulatory
diseases; and GBP231,000 in Relayware Limited, a company providing
software systems to multinational companies allowing them to manage
their indirect sales channels.
Overall, the value of the Company's unquoted investment portfolio
increased by GBP1,837,000 during the year, while that of the small AIM
portfolio fell by GBP55,000.
Amongst the unquoted investments, good progress was made by Radnor House
School, which has recently launched its Sixth Form enabling it to expand
its student numbers further. Oakland Care Centre Limited and Taunton
Hospital Limited are experiencing increasing demand for their services
with consequent growth in profits. The renewable energy investments
have also appreciated in value. In the growth portfolio, Masters
Pharmaceuticals and Hilson Moran are growing profitably, while many of
the technology investments are making good progress in expanding their
businesses. Against this, Helveta has struggled to gain sufficient
commercial traction within the constraints of its available funding and
has been placed into administration, leading to a further reduction in
its value to GBP22,000. The three hotel investments in the portfolio
are also seeing improved trading over recent months, and the Manager is
cautiously optimistic about their future performance.
Risks and uncertainties
The UK economic climate is improving and so is investment sentiment,
though a number of risks remain. The Company's investment portfolio is
well diversified and many of the sectors in which its portfolio
companies operate are resilient. Approximately two-thirds of the
unquoted portfolio is invested in companies with tangible assets, which
support their valuation. It remains the Company's general policy that
portfolio companies should have no external bank borrowings, which
reduces financial risk. In addition, we believe the new portfolio
companies are positioned to grow despite the broader economic
uncertainties. Therefore, as the investment portfolio continues to
mature, the prospects on the whole look positive. A detailed review of
risk management is set out in the Strategic report.
Albion VCTs Top Up Offers 2013/2014
The Albion VCTs Top Up Offers 2013/2014 launched on 6 November 2013.
Following higher than anticipated demand for the offer, Albion Ventures
took the decision to launch the Albion VCTs Prospectus Top Up Offers
2013/2014 on 19 March 2014, working within a very short timescale in
order to capitalise on the opportunity. An encouraging level of
subscriptions have been received across both Offers, raising GBP3.2m for
Crown Place VCT PLC. Following full subscription, the Albion Prospectus
Top Up Offers 2013/2014 closed for the Company on 24 September 2014. The
proceeds of the Offers have been used to provide further resources to
the Company at a time when a number of attractive new investment
opportunities are being seen.
Further Top Up Offers are planned for later this year and details are
expected to be sent to shareholders in November 2014.
Dividend re-investment scheme
During the year the Company raised GBP166,000 from the dividend
re-investment scheme. Through the scheme, shareholders may elect to
reinvest the whole of the dividend received by subscribing for new
shares in the Company. Under current tax rules, individual shareholders
re-investing their dividends will be eligible for the income and capital
gains tax advantages available to investors subscribing to new shares in
venture capital trusts and will be able to increase their shareholding
in the Company simply and without incurring dealing costs or stamp duty.
Full details of the scheme and the application form are available on the
Manager's website at: www.albion-ventures.co.uk/ourfunds/CRWN.
Board composition
Having served on the Board for over 8 years, I have decided to retire at
the forthcoming Annual General Meeting. I would like to thank my fellow
Directors, the Manager and particularly the Shareholders for their
support. Richard Huntingford, who has been on the Board since May 2012,
will succeed me as Chairman and I wish him and the Company well for the
future. The Board will seek to appoint a new independent director in due
course.
Outlook and prospects
While we are seeing continuing improvement in the economic environment
in the UK and increased demand for growth funding by smaller companies,
access to traditional funding channels remain difficult. Your Company
has capitalised on this opportunity to make 11 new investments during
the financial year, more than doubling its investment rate from the
previous year, and the investment pipeline remains strong. The Manager
has strong proprietary deal flow, enabling it to achieve reasonable
entry valuations and attractive investment structures.
The Company's portfolio is well diversified. It includes a number of
investments in more resilient sectors, such as healthcare, education and
renewable energy, as well as companies with good growth prospects. In
addition, the great majority of investments are structured to be cash
generative in order to provide further support for your Company's
dividend. We look forward to the current financial year with
confidence.
Patrick Crosthwaite
Chairman
2 October 2014
Strategic report
Investment objective and policy
The Company's investment objective is to provide investors with a
regular and predictable source of income, combined with the prospect of
longer term capital growth. The Company's investment portfolio is thus
structured to provide a balance between income and capital growth for
the longer term through a diversified, balanced approach to investment.
The asset-based portfolio, which currently accounts for about two-thirds
of unquoted investments by value, is designed to provide stability and
income whilst maintaining the potential for capital growth. The growth
portfolio is intended to provide diversified exposure through its
portfolio of investments predominately in unquoted UK companies. In
neither category do portfolio companies normally have any external
borrowing with a charge ranking ahead of the Company.
Business model
The Company operates as a Venture Capital Trust. This means that the
Company has no employees other than its Directors and has outsourced the
management of all its operations to Albion Ventures LLP, including
secretarial and administrative services. Further details of the
Management agreement can be found below.
Current portfolio sector allocation
The pie chart at the end of this announcement shows the split of the
portfolio valuation by industrial or commercial sector as at 30 June
2014. The portfolio remains well diversified and as at the year end
comprised 56 investments. There were 26 unquoted asset-based investments
accounting for 60 per cent. of the net asset value of the Company, 27
unquoted growth investments accounting for 32 per cent. of the net asset
value of the Company and 3 AIM quoted investments, accounting for 3 per
cent. of the net asset value of the Company.
Direction of portfolio
During the year, the Company continued to increase its exposure to the
less cyclical healthcare and renewable energy sectors which, in addition
to the education sector, now account for approximately 45 per cent. of
the portfolio value.
Looking ahead, the healthcare sector will continue to be a core area of
investment, both in asset-based businesses such as psychiatric hospitals
and care homes, and in medical technology. Additional renewable energy
investments in the current pipeline will allow the Company to reach its
target of 15 per cent. of the portfolio - their main role being to
provide more stable, long term, inflation protected income flows to the
Company. The IT sector of the portfolio has grown during the year as we
have made a number of investments to back new technology developments,
such as e-mail encryption and contextual analysis for on-line
advertising. The education investment, in the form of Radnor House
School, is expected to grow in time as we aim to fund further premises
for growth in student numbers, subject to availability of a suitable
site.
Results and dividend policy
GBP'000
Consolidated revenue return for the year ended 30
June 2014 525
Consolidated capital return for the year ended 30
June 2014 1,451
Dividend of 1.25p per share paid on 29 November 2013 (1,053)
Dividend of 1.25p per share paid on 31 March 2014 (1,079)
Transferred from reserves (156)
Net assets as at 30 June 2014 29,050
Net asset value per share as at 30 June 2014 (pence) 32.04p
As described in the Chairman's statement, the Board has declared a first
dividend for the year ending 30 June 2015 of 1.25 pence per share. This
dividend will be paid on 28 November 2014 to shareholders on the
register as at 7 November 2014.
As shown in the Group's statement of comprehensive income, investment
income has decreased slightly to GBP925,000 (2013: GBP967,000). This is
as a result of the disposal of high yielding loan stock investments in
the previous year, resulting in a decrease of revenue return to
GBP525,000 (2013: GBP590,000). The capital return for the year was a
profit of GBP1,451,000 (2013: GBP1,136,000), as a result of unrealised
gains on investments, in particular Radnor House School, Tower Bridge
Health Club and Oakland Care Centre, offset by management fees charged
to capital. The total return for the year was 2.28 pence per share
(2013: 2.14 pence per share).
The Consolidated balance sheet shows that the net asset value has
decreased slightly over the year to 32.04 pence per share (2013: 32.26
pence per share), due to the payment of the dividend of 2.50 pence per
Albion Crown Vct (LSE:CRWN)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Albion Crown Vct (LSE:CRWN)
Historical Stock Chart
Von Jul 2023 bis Jul 2024